These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness. Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics in the age of personalized medicine. Dickmann LJ; Ware JA Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982 [TBL] [Abstract][Full Text] [Related]
11. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis. Kapoor R; Tan-Koi WC; Teo YY Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547 [TBL] [Abstract][Full Text] [Related]
12. [Personalised pharmacotherapy in intensive care unit patients]. Bellmann R Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology. Landeck L; Kneip C; Reischl J; Asadullah K Exp Dermatol; 2016 May; 25(5):333-9. PubMed ID: 27167702 [TBL] [Abstract][Full Text] [Related]
14. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review). Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205 [TBL] [Abstract][Full Text] [Related]
15. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine. Lambers Heerspink HJ; Oberbauer R; Perco P; Heinzel A; Heinze G; Mayer G; Mayer B Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv105-112. PubMed ID: 26209732 [TBL] [Abstract][Full Text] [Related]
16. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice]. Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and breast cancer management: current status and perspectives. Ciccolini J; Fanciullino R; Serdjebi C; Milano G Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018 [TBL] [Abstract][Full Text] [Related]